Boehringer Ingelheim Pharmaceuticals, Inc. Retains Allscripts; Physicians Interactive Group of Allscripts to Deliver Latest Clinical Information to Physicians.

CHICAGO -- The Physicians Interactive Group of Allscripts (Nasdaq:MDRX), the leading provider of clinical software, connectivity and information solutions that physicians use to improve healthcare, today announced their selection by Boehringer Ingelheim Pharmaceuticals, Inc (BIPI) to be the preferred provider of e-Detailing services across multiple therapeutic areas. The Physicians Interactive Group of Allscripts has established itself as the market leader of online clinical information and education solutions for physicians and healthcare professionals.

With the plethora of available information, patients are becoming more educated on the prescription drugs they consume and require their physician to have even greater levels of product knowledge. With time at a premium, it is becoming increasingly difficult for physicians to find time in the workday to gather the information they need to make informed decisions at the point-of-care. PI e-Detailing(TM) brings this information to the physician in a simple way that fits into their schedule, utilizing the power of the Internet to connect physicians to emerging clinical information through interactive educational programs available 24 hours a day, 7 days a week.

"We are excited to be able to provide these services to BIPI," said Mark Thierer, President of the Physicians Interactive Group of Allscripts. "Our vision is to develop innovative solutions that are indispensable to physicians. PI e-Detailing provides physicians anytime, anywhere access to educational programs on the latest clinical studies, safety reports, and efficacy findings, delivering the right information to support evidenced-based clinical decisions."

The Physicians Interactive Group of Allscripts is the leading provider of e-Detailing and other clinical information and patient adherence solutions that connect healthcare providers to the forefront of medicine. Allscripts has developed over 450 online programs for more than 100 brands in every stage of the product life cycle. Continuing its leadership in the industry, Allscripts works with more than 50 pharmaceutical, biotech, and medical device clients, including eight of the top 10 worldwide pharmaceutical firms.

About Boehringer Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is the largest U.S. subsidiary of Boehringer Ingelheim Corporation (Ridgefield, CT) and a member of the Boehringer Ingelheim group of companies.

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 152 affiliates in 45 countries and more than 34,000 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.

In 2003, Boehringer Ingelheim posted net sales of US $8.37 billion (7.4 billion euro) while spending more than one fifth of net sales in its largest business segment, Prescription Medicines, on research and development.

For more information please visit www.boehringer-ingelheim.com.

About Allscripts

Allscripts Healthcare Solutions (Allscripts) is the leading provider of clinical software, connectivity and information solutions that physicians use to improve healthcare. The Company's business groups provide unique solutions that inform, connect, and transform healthcare. The Clinical Solutions Group's award-winning clinical software applications include electronic health record (EHR), e-prescribing and document imaging solutions. Additionally, Allscripts provides clinical product education and connectivity solutions for physicians and patients through its Physicians Interactive(TM) Group and medication fulfillment services through its Medication Services Group. Visit Allscripts on the Web at www.allscripts.com.

This announcement may contain forward-looking statements about Allscripts Healthcare Solutions that involve risks and uncertainties. These statements are developed by combining currently available information with Allscripts beliefs and assumptions. Forward-looking statements do not guarantee future performance. Because Allscripts cannot predict all of the risks and uncertainties that may affect it, or control the ones it does predict, Allscripts' actual results may be materially different from the results expressed in its forward-looking statements. For a more complete discussion of the risks, uncertainties and assumptions that may affect Allscripts, see the Company's 2004 Annual Report on Form 10-K, available through the Web site maintained by the Securities and Exchange Commission at www.sec.gov.